<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">9111376</journal-id>
<journal-id journal-id-type="pubmed-jr-id">2201</journal-id>
<journal-id journal-id-type="nlm-ta">Curr Opin Neurobiol</journal-id>
<journal-id journal-id-type="iso-abbrev">Curr. Opin. Neurobiol.</journal-id>
<journal-title-group>
<journal-title>Current opinion in neurobiology</journal-title>
</journal-title-group>
<issn pub-type="ppub">0959-4388</issn>
<issn pub-type="epub">1873-6882</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30703685</article-id>
<article-id pub-id-type="pmc">6629480</article-id>
<article-id pub-id-type="doi">10.1016/j.conb.2018.12.013</article-id>
<article-id pub-id-type="manuscript">NIHMS1519793</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Alternative Splicing of Neuronal Genes: New mechanisms and New Therapies</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Lipscombe</surname>
<given-names>Diane</given-names>
</name>
<degrees>PhD</degrees>
<aff id="A1">Robert J and Nancy D Carney Institute for Brain Science, Department of Neuroscience, Brown University. Providence, RI 02912, USA. <email>diane_lipscombe@brown.edu</email></aff>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Soto</surname>
<given-names>Eduardo Javier Lopez</given-names>
</name>
<degrees>PhD</degrees>
<aff id="A2">Robert J and Nancy D Carney Institute for Brain Science, Department of Neuroscience, Brown University. Providence, RI 02912, USA. <email>ejlopezsoto@gmail.com</email>, <email>eduardo_lopez_soto@brown.edu</email></aff>
</contrib>
</contrib-group>
<author-notes>
<corresp id="CR1"><bold>Corresponding author</bold>: Diane Lipscombe PhD, <email>diane_lipscombe@brown.edu</email>, Robert J and Nancy D Carney Institute for Brain Science, Department of Neuroscience, Brown University. Providence, RI 02912, USA.</corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>8</day>
<month>2</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="epub">
<day>28</day>
<month>1</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="ppub">
<month>8</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>8</month>
<year>2020</year>
</pub-date>
<volume>57</volume>
<fpage>26</fpage>
<lpage>31</lpage>
<!--elocation-id from pubmed: 10.1016/j.conb.2018.12.013-->
<abstract id="ABS1">
<p id="P1">Dynamic changes in alternative splicing during the life cycle of neurons supports development, plasticity, and is implicated in disease pathology. Cell-specific alternative splicing programs coordinate exon selection across networks of functionally connected genes. In this opinion piece we highlight recent publications that identify some of the molecular mechanisms – RNA and DNA binding proteins and epigenetic modifications – which direct cell specific exon selection during pre-mRNA splicing. Aberrant splicing patterns are signature features of a growing number of diseases of the nervous system. Recent publications demonstrate the value of delineating basic mechanisms that dictate exon choice to inform the development of new therapeutic strategies that correct or compensate for damaging deficits in alternative splicing.</p>
</abstract>
</article-meta>
</front>
</article>
</pmc-articleset>